This session reviews miscellaneous and future applications of radiopharmaceutical therapy, many of which are under development or in use outside of the U.S. The presenter discusses radiopharmaceutical applications such as meta-iodobenzylguanidine (MIBG) therapy, topical rhenium skin cancer therapy, radiosynoviorthesis, palliative radiopharmaceutical therapies, indications in hematologic malignancies, and the increasing role of alpha emitters in radiopharmaceutical therapies. The presenter also touches on how to become an authorized user for administration of radiopharmaceutical therapies.

Topics:

• Miscellaneous and Future Applications for Radiopharmaceutical Therapy / How To Become an Authorized User ‒ Michael Folkert, MD, PhD
• New Isotopes and Indications in Radiopharmaceutical Therapy ‒ Michael Folkert, MD, PhD